| GRANT | DATE | AMOUNT | PROGRAM |
|---|---|---|---|
|
You're Just My Type Inc
Capacity building support - phase II |
09.09.2026 | $180,000.00 | Type 1 Diabetes, Improve Outcomes |
|
Seattle Children's Hospital
Restoring Immune Tolerance in Type 1 Diabetes Using Antigen-Specific Regulatory B Cells |
08.05.2026 | $2,225,812.00 | Type 1 Diabetes, Prevent & Delay |
|
Diabetes Education and Camping Association, Inc.
Capacity building support |
07.22.2026 | $568,000.00 | Type 1 Diabetes, Improve Outcomes |
|
King's College London
Continuation of the Prenatal drivers of infant ISlet Autoimmunity (PISA) study |
07.22.2026 | $3,064,295.00 | Type 1 Diabetes, Prevent & Delay |
|
The Regents of the University of California at Irvine
Development of a continuous insulin sensor |
07.22.2026 | $3,499,579.00 | Type 1 Diabetes, Improve Outcomes |
|
Seattle Children's Hospital
Expanding use of engineered Treg therapy for application across the majority of T1D subjects (Phase 5) |
06.24.2026 | $921,780.00 | Type 1 Diabetes, Prevent & Delay |
|
Board of Trustees of the Leland Stanford Junior University
Efficacy of the NYC DMC intervention for youth with T1D |
06.24.2026 | $978,795.00 | Type 1 Diabetes, Improve Outcomes |
|
Fondation de soutien à l'Organisation Mondiale de la Santé
Technical leadership for diabetes and PEN-Plus implementation |
06.10.2026 | $11,124,732.00 | Type 1 Diabetes, Improve Outcomes |
|
International Alliance for Diabetes Action Inc
IADA Phase 2: Strengthening and sustaining coordination for diabetes care in humanitarian settings |
06.10.2026 | $2,579,400.00 | Type 1 Diabetes, Improve Outcomes |
|
College Diabetes Network, Inc.
Capacity building support |
06.10.2026 | $1,500,000.00 | Type 1 Diabetes, Improve Outcomes |
|
Jaeb Center For Health Research Foundation, Inc.
Data management and site coordination for clinical study evaluating an AID system for pregnant individuals with T1D |
05.20.2026 | $1,368,321.00 | Type 1 Diabetes, Improve Outcomes |
|
Trustees of Indiana University
Evaluation of a novel glucose responsive insulin (GRI) |
05.20.2026 | $1,576,559.00 | Type 1 Diabetes, Improve Outcomes |
|
Foundation for Innovative New Diagnostics FIND
Access to Continuous Glucose Monitoring for Equity in Diabetes Management 2.0 (ACCEDE 2.0): Scaling sustainable access models for affordable, quality-assured CGMs in Africa and Asia through evidence generation, policy engagement, improving market health, and capacity strengthening |
05.06.2026 | $3,171,729.00 | Type 1 Diabetes, Improve Outcomes |
|
Washington University
Modeling T1D glucagon secretion and screening modulatory compounds |
05.06.2026 | $550,000.00 | Type 1 Diabetes, Prevent & Delay |
|
American Diabetes Association, Inc.
ADA Training and Mentorship - The Connected Journey |
03.24.2026 | $3,000,000.00 | Type 1 Diabetes, Improve Outcomes |
|
Vivli, Inc.
Making T1D datasets publicly available |
03.12.2026 | $150,000.00 | Type 1 Diabetes, Improve Outcomes |
|
Université libre de Bruxelles
Advancing toward a first-in-human beta cell imaging trial using a single domain antibody targeting DPP6 |
02.26.2026 | $1,137,649.00 | Type 1 Diabetes, Prevent & Delay |
|
Mass General Brigham for the Massachusetts General Hospital
Leveraging immunosuppressive myeloid function to prevent type I diabetes |
01.12.2026 | $897,746.00 | Type 1 Diabetes, Prevent & Delay |
|
Tidepool Project
Expansion of the Tidepool+ Platform |
01.12.2026 | $3,000,000.00 | Type 1 Diabetes, Improve Outcomes |
|
The University of British Columbia
High-dimensional analysis of innate immune cells in T1D pancreas |
01.12.2026 | $900,000.00 | Type 1 Diabetes, Prevent & Delay |
|
Prev
12...48
Next
1 - 20 of 948 results
|
|||